Gene · 325
Papers4,193
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 4,193
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Complex Role of C-Reactive Protein in Systemic Lupus Erythematosus. | J Clin Med | 2021 | 34945133 | PubTator, text mining | PubMed |
| Antibody and Protein Profiles in Glaucoma: Screening of Biomarkers and Identification of Signaling Pathways. | Biology (Basel) | 2021 | 34943212 | PubTator, text mining | PubMed |
Effects of nutritional support combined with insulin therapy on serum proteins, inflammatory factors, pentraxin-3, and serum amylase levels in patients with diabetic ketoacidosis complicated with acute pancreatitis. | Medicine (Baltimore) | 2021 | 34941035 | PubTator, text mining | PubMed |
| Proteomic mapping of atrial and ventricular heart tissue in patients with aortic valve stenosis. | Sci Rep | 2021 | 34937869 | PubTator, text mining | PubMed |
| Cardiac Transthyretin Amyloidosis: Hidden in Plain Sight. | Case Rep Med | 2021 | 34917152 | PubTator, text mining | PubMed |
| The role of pentraxin3 in plasma and bronchoalveolar lavage fluid in COPD patients with invasive pulmonary aspergillosis. | BMC Pulm Med | 2021 | 34915889 | PubTator, text mining | PubMed |
| How Times Have Changed! A Cornucopia of Antigens for Membranous Nephropathy. | Front Immunol | 2021 | 34899763 | PubTator, text mining | PubMed |
Effects of immunoglobulin plus prednisolone in reducing coronary artery lesions in patients with Kawasaki disease: study protocol for a phase III multicenter, open-label, blinded-endpoints randomized controlled trial. | Trials | 2021 | 34895290 | PubTator, text mining | PubMed |
| A Pilot Study of Rare Renal Amyloidosis Based on FFPE Proteomics. | Molecules | 2021 | 34885818 | PubTator, text mining | PubMed |
| Influence of Risk Factors for Male Infertility on Sperm Protein Composition. | Int J Mol Sci | 2021 | 34884971 | PubTator, text mining | PubMed |
| Complementary Roles of Short and Long Pentraxins in the Complement-Mediated Immune Response to Aspergillus fumigatus Infections. | Front Immunol | 2021 | 34868070 | PubTator, text mining | PubMed |
| Acute Phase Proteins Are Baseline Predictors of Tuberculosis Treatment Failure. | Front Immunol | 2021 | 34867953 | PubTator, text mining | PubMed |
| Elevated plasma pentraxin-3 in polycystic ovary syndrome is associated with hyperandrogenism: a case-control study. | BMC Endocr Disord | 2021 | 34856980 | PubTator, text mining | PubMed |
| Clinical and Prognostic Implications of 1p/19q, IDH, BRAF, MGMT Promoter, and TERT Promoter Alterations, and Expression of Ki-67 and p53 in Human Gliomas. | Cancer Manag Res | 2021 | 34849029 | PubTator, text mining | PubMed |
| Role of Photobiomodulation Therapy in Neurological Primary Burning Mouth Syndrome. A Systematic Review and Meta-Analysis of Human Randomised Controlled Clinical Trials. | Pharmaceutics | 2021 | 34834253 | PubTator, text mining | PubMed |
| The Potential Contribution of Biopolymeric Particles in Lung Tissue Regeneration of COVID-19 Patients. | Polymers (Basel) | 2021 | 34833310 | PubTator, text mining | PubMed |
| Molecular Mechanisms and Cellular Contribution from Lung Fibrosis to Lung Cancer Development. | Int J Mol Sci | 2021 | 34830058 | PubTator, text mining | PubMed |
| Extracellular Matrix in Heart Failure: Role of ADAMTS5 in Proteoglycan Remodeling. | Circulation | 2021 | 34806902 | PubTator, text mining | PubMed |
| Genetic analysis of pharmacogenomic VIP variants in the Wa population from Yunnan Province of China. | BMC Genom Data | 2021 | 34798807 | PubTator, text mining | PubMed |
| Localized amyloidosis of the prostatic urethra mimicking urothelial carcinoma. | Am J Clin Exp Urol | 2021 | 34796257 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/325/papers?page=29